Terry Cho

Sr. Director, Clinical Operations at QED Therapeutics - Palo Alto, CA, US

Terry Cho's Colleagues at QED Therapeutics
Hiywot MS

Director Clinical Operations

Contact Hiywot MS

Devendra A.

Associate Director, Statistical Programming

Contact Devendra A.

Timothy Bisson

Senior Director- Market Access

Contact Timothy Bisson

Quinn Nazarewycz

Senior Director, Marketing

Contact Quinn Nazarewycz

Jennifer Lai

Regulatory Affairs Manager

Contact Jennifer Lai

Shivani Pandit

regulatory affairs manager

Contact Shivani Pandit

View All Terry Cho's Colleagues
Terry Cho's Contact Details
HQ
650-231-4088
Location
Company
QED Therapeutics
Terry Cho's Company Details
QED Therapeutics logo, QED Therapeutics contact details

QED Therapeutics

Palo Alto, CA, US • 100 - 249 Employees
BioTech/Drugs

QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.

N/A
Details about QED Therapeutics
Frequently Asked Questions about Terry Cho
Terry Cho currently works for QED Therapeutics.
Terry Cho's role at QED Therapeutics is Sr. Director, Clinical Operations.
Terry Cho's email address is ***@qedtx.com. To view Terry Cho's full email address, please signup to ConnectPlex.
Terry Cho works in the Biotechnology industry.
Terry Cho's colleagues at QED Therapeutics are Hiywot MS, Devendra A., Timothy Bisson, Quinn Nazarewycz, Jennifer Lai, Shivani Pandit, Chelsea Guiseppi and others.
Terry Cho's phone number is 650-231-4088
See more information about Terry Cho